Flat ₹100 OFF on First app order | Use Code: APP100 |
Flat ₹100 OFF
on First app order
Use Code
APP100
Download Now
100% Same
Salt CompositionEffectivenessStrength
Top Branded
Substitute
Salt Composition in bothTolvaptan 30mg
Hyponat-O 30mg Tablet
You Searched
Hyponat-O 30mg Tablet
Zydus Cadila
₹490
Our Recommendation
Tolvaheal 30mg Tablet 10s
1,308+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Treatment of Low levels of sodium in the blood
Customers also bought
More About Hyponat-O
Benefits
In Treatment of Low levels of sodium in the blood Low levels of sodium may be caused due to multiple reasons such as excess of body fluids, heart disease, and kidney problems. There may be many symptoms such as nausea, headache confusion and the person may even need to get hospitalized. Hyponat-O 30mg Tablet helps to get rid of the excess fluids and retains sodium in the blood. This restores the normal sodium levels in our body and prevents further complications such as memory loss.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Hyponat-O 30mg Tablet can be taken it with or without food, although it's advisable to take it consistently at the same time.
How it works
Hyponat-O 30mg Tablet is a vasopressin antagonist. It works by blocking the effect of the hormone vasopressin in the body. This increases urine production, reduces the amount of water in the blood and raises the blood sodium level.
Caution: It is important to consult your doctor regarding alcohol consumption while taking Hyponat-O 30mg Tablet .
Seek medical advice from your doctor: Hyponat-O 30mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Seek medical advice from your doctor: Hyponat-O 30mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Not Safe: Hyponat-O 30mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Safe when prescribed by an expert: Hyponat-O 30mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Hyponat-O 30mg Tablet is recommended. However, the use of Hyponat-O 30mg Tablet is not recommended in patients with severe kidney disease.
Caution Advised: Hyponat-O 30mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Hyponat-O 30mg Tablet may be needed. Doctor consultation is advised. Use of Hyponat-O 30mg Tablet is not recommended in patients with severe liver disease.
What if I forget to take it?
If a dose of Hyponat-O 30mg Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
Zydus Tower, Satellite Cross Roads,Ahmedabad ‚ 380015 Gujarat, India.
References
Reilly RF, Jackson EK. Regulation of Renal Function and Vascular Volume. In: Brunton LL, Chabner BA, Knollmann BC,12th ed. editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 714
Masters SB. Hypothalamic & Pituitary Hormones. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 659
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1379-80
Tolvaptan. Otsuka Pharmaceutical Co.; 2009
ScienceDirect. Tolvaptan (04 Apr. 2019)
PubChem. Tolvaptan (04 Apr. 2019)
Tolvaptan. Wexham, UK: Otsuka Pharmaceuticals (UK) Ltd.; 2015 (22 Feb. 2019)
Tolvaptan (07 Aug. 2023)
Rangarajan B, Binoy V, Hingmire SS, Noronha V. Tolvaptan. South Asian J Cancer. 2014 Jul;3(3):182-4 (07 Aug. 2023)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.